Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 10,300
-30 (-0.29%)
Sep 11, 2026, 3:30 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 190.38 billion as of September 11, 2026. Its market cap has increased by 15.47% in one year.
Market Cap
190.38B
Enterprise Value
124.31B
Revenue
273.47B
Ranking
n/a
PE Ratio
8.80
Stock Price
10,300.00
ChartMarket Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 190.38B, an increase of 271.70%. That is a compound annual growth rate of 4.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 190.38B | 10.16% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 226.40B |
| HLB Pharmaceutical | 217.46B |
| Yungjin Pharm. | 192.04B |
| REYON Pharmaceutical | 185.06B |
| Chong Kun Dang Holdings | 184.95B |
| AptaBio Therapeutics | 178.39B |
| BNC KOREA | 176.80B |
| FutureChem Co.,Ltd | 175.57B |